Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Innovations and highlights in the Pharma industry 

Dive deep into the world of Pharma with Zamann’s Expert Blog. Our industry-leading professionals share insights on global project management, quality consultancy, digitalization, and more. Stay updated with trends and innovations transforming the Pharma industry. 

News and more

Top 10 Steps for Qualifying a New GMP Facility

The qualification of a GMP facility is essential to ensure the high standards of pharmaceutical production and to guarantee product quality. In our latest article, you will learn the 10 most important steps for the successful qualification of a new
  • GMP, GxP, Validation and Qualification

NDSRI Regulatory reporting requirements and their timeline

Navigating NDSRI regulatory reporting requirements is crucial for pharmaceutical companies to ensure compliance and patient safety. These regulations mandate timely and accurate reporting of nitrosamine impurities in medicines. Understanding the timeline for these requirements helps streamline processes and avoid costly
  • Nitrosamine

ISO 9001: Level Up Your Medical Device QMS

In the world of medical devices, where even minor flaws can have life-altering consequences, a robust Quality Management System (QMS) is paramount. This system ensures consistent quality, adherence to regulations, and ultimately, patient safety. While various standards exist, ISO 9001
  • ISO 9001, Medical Devices
wooden cubes with the letter ISO and the right sign.

4 Key OQ Mistakes in Pharma to Avoid

Operational Qualification (OQ) is crucial in pharmaceutical manufacturing for ensuring compliance and product quality. This article outlines common OQ mistakes—such as inadequate planning, misunderstanding scope, poor documentation, and neglecting verification—and offers strategies to enhance quality assurance and safeguard patient safety.
  • Equipment Qualification, Validation and Qualification
Young woman wearing lab coat operating equipment in workshop

6 Steps to reduce nitrosamines impurities in Pharma industry

Implementing effective strategies involves six crucial steps: conducting thorough risk assessments, optimizing manufacturing processes, using high-purity raw materials, performing rigorous analytical testing, adhering to regulatory guidelines, and maintaining continuous monitoring and quality control. These measures collectively minimize nitrosamine risks in
  • Nitrosamine

Agile Meets GAMP 5: Streamlining CSV

Explore the integration of Agile methodology into Computer System Validation (CSV) guided by GAMP 5 principles. This approach offers enhanced flexibility, faster validation, and improved compliance, ensuring your software systems meet regulatory standards efficiently.
  • Computerized System Validation, GAMP 5

5-Step CAPA for FDA Compliance

Effective CAPA is key to medical device quality, but meeting FDA's CFR Part 820 QSR requirements is just the first step. Pitfalls like shallow investigations and reactive approaches can still land you in hot water. Zamann Pharma Support helps you
  • CAPA Management, Quality Management System
FDA concept - Food and Drug Administration medicine recalls guidelines

The Role of Big Data in Nitrosamine Risk Assessment

In the pharmaceutical industry, nitrosamines pose significant health risks due to their carcinogenic potential. This blog explores how big data analytics revolutionizes nitrosamine risk assessment by enabling accurate monitoring and prediction. By leveraging vast datasets and predictive models, companies can
  • Nitrosamine